197 related articles for article (PubMed ID: 728284)
1. Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability.
Bryson SM; Whiting B; Lawrence JR
Br J Clin Pharmacol; 1978 Nov; 6(5):409-19. PubMed ID: 728284
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure.
Landmark K; Bredesen JE; Thaulow E; Simonsen S; Amlie JP
Eur J Clin Pharmacol; 1981 Feb; 19(3):187-92. PubMed ID: 7215416
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the anticholinergic effects of two formulations of disopyramide in healthy volunteers.
Longmore J; Berry JL; Szabadi E; Bradshaw CM
Eur J Clin Pharmacol; 1990; 39(3):305-9. PubMed ID: 2257872
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog.
Karim A; Kook C; Novotney RL; Zagarella J; Campion J
Drug Metab Dispos; 1978; 6(3):338-45. PubMed ID: 26556
[TBL] [Abstract][Full Text] [Related]
5. The effects of urine pH and plasma protein binding on the renal clearance of disopyramide.
Cunningham JL; Shen DD; Shudo I; Azarnoff DL
Clin Pharmacokinet; 1977; 2(5):373-83. PubMed ID: 21054
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of the disopyramide concentration-effect relationship.
Whiting B; Holford NH; Sheiner LB
Br J Clin Pharmacol; 1980 Jan; 9(1):67-75. PubMed ID: 7356895
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic and metabolic study of disopyramide in oral and intravenous administration].
De Graeve J; Kremers P; Gielen JE
Therapie; 1977; 32(2):195-204. PubMed ID: 898127
[No Abstract] [Full Text] [Related]
8. The absorption of disopyramide in animals determined using a stable isotope co-administration technique.
Haskins NJ; Waddell KA; Ford GC; Spalton PN; Walls CM; Forrest TJ; Palmer RF
Biomed Mass Spectrom; 1980 Feb; 7(2):80-3. PubMed ID: 7407335
[TBL] [Abstract][Full Text] [Related]
9. Disopyramide pharmacokinetics during recovery from myocardial infarction.
Bryson SM; Cairns CJ; Whiting B
Br J Clin Pharmacol; 1982 Mar; 13(3):417-21. PubMed ID: 7059444
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability assessment of disopyramide using pharmacokinetic-pharmacodynamic (PK-PD) modeling in the rat.
Miyazaki M; Maekawa C; Iwanaga K; Morimoto K; Kakemi M
Biol Pharm Bull; 2000 Nov; 23(11):1363-9. PubMed ID: 11085367
[TBL] [Abstract][Full Text] [Related]
11. Influence of concentration-dependent protein binding on serum concentrations and urinary excretion of disopyramide and its metabolite following oral administration.
Haughey DB; Lima JJ
Biopharm Drug Dispos; 1983; 4(2):103-12. PubMed ID: 6882879
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans.
Aitio ML; Allonen H; Kanto J; Mäntylä R
Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):219-26. PubMed ID: 7095921
[TBL] [Abstract][Full Text] [Related]
13. Disopyramide hemodialysis and kinetics in patients requiring long-term hemodialysis.
Sevka MJ; Matthews SJ; Nightingale CH; Izard MW; Fieldman A; Chow MS
Clin Pharmacol Ther; 1981 Mar; 29(3):322-6. PubMed ID: 7471602
[TBL] [Abstract][Full Text] [Related]
14. Disopyramide phosphate: tissue uptake and relationship between drug concentrations in the plasma and myocardium of rats.
Karim A; Kook C; Campion J; Doherty M
Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):222-36. PubMed ID: 921413
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of disopyramide administered by intramuscular, intravenous and oral routes to normal volunteers [proceedings].
Ashford JJ; Carmichael D; Kidner PH
Br J Pharmacol; 1979 Jul; 66(3):442P-443P. PubMed ID: 526732
[No Abstract] [Full Text] [Related]
16. Disopyramide pharmacokinetics and bioavailability.
Dubetz DK; Brown NN; Hooper WD; Eadie MJ; Tyrer JH
Br J Clin Pharmacol; 1978 Sep; 6(3):279-81. PubMed ID: 687507
[No Abstract] [Full Text] [Related]
17. Disopyramide in acute myocardial infarction: problems with changing pharmacokinetics.
Elliott HL; Thomson AH; Bryson SM
Eur J Clin Pharmacol; 1986; 30(3):345-7. PubMed ID: 3732373
[TBL] [Abstract][Full Text] [Related]
18. Disopyramide kinetics in patients with acute myocardial infarction.
Ilett KF; Madsen BW; Woods JD
Clin Pharmacol Ther; 1979 Jul; 26(1):1-7. PubMed ID: 445953
[TBL] [Abstract][Full Text] [Related]
19. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
Cook CS; Karim A; Sollman P
Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395
[TBL] [Abstract][Full Text] [Related]
20. The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide.
Giacomini KM; Swezey SE; Turner-Tamiyasu K; Blaschke TF
J Pharmacokinet Biopharm; 1982 Feb; 10(1):1-14. PubMed ID: 7069575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]